| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018773879 |
| P356 | DOI | 10.1385/IR:27:1:53 |
| P698 | PubMed publication ID | 12637768 |
| P50 | author | Andrew Taylor-Robinson | Q43073586 |
| P2093 | author name string | Andrew W Taylor-Robinson | |
| P2860 | cites work | Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes | Q24338522 |
| Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine | Q24650662 | ||
| Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells | Q24679783 | ||
| HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage | Q28138607 | ||
| Common west African HLA antigens are associated with protection from severe malaria | Q28288693 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| Non-CS pre-erythrocytic protective antigens | Q58840097 | ||
| Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways | Q59050520 | ||
| Sporozoite invasion | Q60064340 | ||
| RNA Bacteriophage Capsid-Mediated Drug Delivery and Epitope Presentation | Q61798814 | ||
| Expression of Plasmodium berghei circumsporozoite antigen on the surface of exoerythrocytic schizonts and merozoites | Q69528856 | ||
| Immunity to intracellular bacteria | Q70667383 | ||
| Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis | Q71049413 | ||
| Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration | Q72234412 | ||
| In vitro infectivity of irradiated Plasmodium berghei sporozoites to cultured hepatoma cells | Q72392034 | ||
| Prometheus through the looking glass: reflections on the hepatic immune system | Q73110629 | ||
| Why does Plasmodium have a pre-erythrocytic cycle? | Q80381123 | ||
| Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes | Q30039117 | ||
| Human T-cell recognition of the circumsporozoite protein of plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule | Q33554105 | ||
| Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya | Q33599649 | ||
| Immune effector mechanisms in malaria | Q33711422 | ||
| A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection. | Q33784968 | ||
| Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism | Q33797447 | ||
| Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials | Q33852285 | ||
| IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model | Q33867200 | ||
| Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. | Q33876788 | ||
| The liver as a site of T-cell apoptosis: graveyard, or killing field? | Q33916575 | ||
| The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites | Q33916604 | ||
| Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3 | Q34003047 | ||
| gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites | Q34003993 | ||
| Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection | Q34007519 | ||
| Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes | Q34055744 | ||
| Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies | Q34255253 | ||
| Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites | Q34408886 | ||
| Medical need, scientific opportunity and the drive for antimalarial drugs | Q34521004 | ||
| IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. | Q34888899 | ||
| Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice | Q34957552 | ||
| T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. | Q35560038 | ||
| The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules | Q36231136 | ||
| CD4+ cytolytic T cell clone confers protection against murine malaria | Q36353821 | ||
| A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection | Q36366985 | ||
| Malaria vaccine development: current status | Q36623410 | ||
| Mouse NK1.1+ T cells: a new family of T cells | Q36819827 | ||
| Recombinant human gamma interferon inhibits simian malaria | Q37025980 | ||
| Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites | Q38905311 | ||
| Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children | Q39195300 | ||
| Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria | Q39195303 | ||
| Immunoregulation of malarial infection: balancing the vices and virtues | Q39514773 | ||
| Research toward vaccines against malaria | Q40859526 | ||
| HIV and HLA: confusion or complexity? | Q40968237 | ||
| Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein | Q41098194 | ||
| Exoerythrocytic Merozoites ofPlasmodium bergheiin Rat Hepatic Kupffer Cells | Q41171308 | ||
| Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules | Q41230821 | ||
| Strange brew: T cells in the liver | Q41265769 | ||
| Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites | Q41386252 | ||
| Molecular analysis of the association of HLA-B53 and resistance to severe malaria | Q41590293 | ||
| T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. | Q41668652 | ||
| Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee | Q41915796 | ||
| An estimation of the number of malaria sporozoites ejected by a feeding mosquito | Q43712453 | ||
| Ultrastructure of in Vitro Cultured Exoerythrocytic Stage of Plasmodium Berghei in a Hepatoma Cell Line | Q43906642 | ||
| Sterile protection of monkeys against malaria after administration of interleukin-12. | Q43923494 | ||
| Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. | Q44138863 | ||
| Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite | Q44143012 | ||
| Infectious diseases. Researchers crack malaria genome | Q44147404 | ||
| In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei from sporozoites | Q44166971 | ||
| CD8+ T-cell protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria | Q44168579 | ||
| A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group | Q44174498 | ||
| Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity | Q44174926 | ||
| Fine structure of the malaria parasite Plasmodium falciparum in human hepatocytes in vitro. | Q44336327 | ||
| The complexity of protective immunity against liver-stage malaria | Q44444824 | ||
| Structure of Plasmodium falciparum liver stage antigen-1 | Q44810337 | ||
| Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes | Q45198054 | ||
| Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models | Q45746483 | ||
| Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations | Q45749788 | ||
| Heterozygote advantage for HLA class-II type in hepatitis B virus infection | Q45760698 | ||
| Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles | Q45769758 | ||
| Predominance of one T-cell antigen receptor BV haplotype in African populations | Q46351289 | ||
| Influence of age and HLA type on interferon-gamma (IFN-gamma) responses to a naturally occurring polymorphic epitope of Plasmodium falciparum liver stage antigen-1 (LSA-1). | Q46445624 | ||
| Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria | Q46548934 | ||
| Biology of malarial liver stages: implications for vaccine design | Q46706713 | ||
| Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. | Q47841349 | ||
| Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum | Q47849915 | ||
| Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids | Q47854339 | ||
| Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites | Q47856882 | ||
| Liver CD4-CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. | Q47858000 | ||
| A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei | Q47858382 | ||
| Factors influencing resistance to reinfection with Plasmodium falciparum | Q47858919 | ||
| Eosinophil-rich, granulomatous inflammatory response to Plasmodium berghei hepatic schizonts in nonimmunized rats is age-related. | Q47869878 | ||
| HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections | Q47873952 | ||
| Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria. | Q47875788 | ||
| A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells | Q47881349 | ||
| Stage-specific ribosomal RNA expression switches during sporozoite invasion of hepatocytes | Q47885910 | ||
| Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon | Q47907672 | ||
| A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning | Q47912684 | ||
| Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite | Q47989675 | ||
| Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. | Q47998916 | ||
| Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria | Q47999376 | ||
| Development of antimalaria immunity in mice lacking IFN-gamma receptor. | Q47999419 | ||
| Protective immunity against malaria: cellular changes in the liver vary according to the method of immunization | Q48025212 | ||
| MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. | Q48026836 | ||
| A protein particle vaccine containing multiple malaria epitopes | Q48037572 | ||
| Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice. | Q54155295 | ||
| Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. | Q54173684 | ||
| Immunogenetics. Defence by diversity. | Q55240127 | ||
| Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime | Q56774528 | ||
| P433 | issue | 1 | |
| P921 | main subject | malaria | Q12156 |
| malaria vaccine | Q6741353 | ||
| vaccine engineering | Q14861085 | ||
| P304 | page(s) | 53-70 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | Immunity to liver stage malaria: considerations for vaccine design | |
| P478 | volume | 27 |
| Q35186079 | Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar |
| Q36908779 | High levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in Myanmar |
| Q81571715 | Mice with chimeric human livers: who says supermodels have to be tall? |
| Q34546201 | Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51 |
| Q21296829 | Tomatine adjuvantation of protective immunity to a major pre-erythrocytic vaccine candidate of malaria is mediated via CD8+ T cell release of IFN-gamma |
| Q36868249 | Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection |
Search more.